GSEA results demonstrate an obvious enrichment of immunoregulatory pathways against cancer in high-risk HCC patients, such as the mTOR signaling pathway, WNT signaling pathway, ERBB signaling pathway, GNRH signaling pathway, NOTCH signaling pathway, and P53 signaling pathway. This evidence concerns the gene TP53 and cancer.